FDA Intervention In Kava Labeling Suit Sought By Jarrow Formulas
This article was originally published in The Tan Sheet
Executive Summary
FDA should release an official statement or publish a proposed rule requiring warnings on kava supplements "if available sound science supports such rulemaking," Jarrow Formulas says in an Oct. 4 citizen petition